Yammine, Luba
Grigson, Patricia Sue
Schmitz, Joy M.
Evans, Brianna B.
Hendershot, Christian S.
Funding for this research was provided by:
National Institute of Drug Abuse (R01 DA053241)
National Institute of Drug Abuse (UH3 DA050325)
National Institute of Drug Abuse (F30 DA057043)
National Institute of Alcohol Abuse and Alcoholism (R21 AA031892)
Pharmacotherapies for Alcohol and Substance Use Alliance (AS210006-A3)
Article History
Accepted: 18 April 2025
First Online: 13 June 2025
Declarations
:
: No animal of human subjects were involved in this study.
: LY has received research funding from Novo Nordisk, Inc. and provided consulting services to Eli Lilly that were outside of this paper. PSG has provided consulting services to Eli Lilly that were outside of this paper. CH has provided consulting services to Eli Lilly and advisory board participation to Apollo Therapeutics that were outside of this paper. JS and BE have nothing to disclose.